Chinese Scientists Develop Electronic Comb That Regrows 98% of Hair in Mice in 28 Days

Chinese Scientists Develop Electronic Comb That Regrows 98% of Hair in Mice in 28 Days

An experimental device called Detangle combines electrical stimulation with targeted drug delivery, offering a new direction in the search for effective baldness treatments.

A comb that could help reverse baldness sounds like something from science fiction. But researchers in China have developed an experimental electronic device that has produced remarkable hair-regrowth results in laboratory mice. Named Detangle, the device achieved approximately 97.85% hair coverage in treated areas within 28 days, outperforming the results obtained with minoxidil, a widely used hair-loss medication.

The research, published in Nature Communications on November 3, 2026, was conducted by scientists from Beihang University in Beijing in collaboration with researchers from City University of Hong Kong. Although the findings are still limited to animal experiments, they offer an interesting new approach to treating androgenetic alopecia, commonly known as male- or female-pattern baldness.

A Global Problem Affecting More Than 1.5 Billion People

Hair loss is more than a cosmetic concern. For many people, progressive baldness affects self-confidence, social interactions and psychological well-being.

The research paper estimates that androgenetic alopecia affects more than 1.5 billion people worldwide. It is the most common form of progressive hair loss and can affect both men and women, although the patterns and age of onset differ.

In men, the condition often begins with a receding hairline or thinning around the crown. In women, it more commonly appears as gradual thinning across the central scalp, with the frontal hairline generally remaining intact.

Genetics and hormonal activity play major roles in the condition. A hormone called dihydrotestosterone (DHT), produced from testosterone through the action of the enzyme 5-alpha-reductase, can gradually shrink genetically susceptible hair follicles. Over time, these follicles produce increasingly thin and short hair until visible growth becomes difficult.

The condition becomes more common with age, although younger adults can also experience noticeable hair loss. Its prevalence varies across populations, making a single percentage for baldness across all countries and age groups misleading.

Existing treatments, including minoxidil and finasteride, can slow hair loss or encourage regrowth in some patients. However, results vary, treatment generally requires continued use, and some patients experience side effects or insufficient improvement.

How Does the Detangle Electronic Comb Work?

The Chinese research team has attempted to address one of the major challenges in hair-loss treatment: delivering therapeutic substances effectively to hair follicles beneath the skin.

Detangle combines two technologies: gentle electrical stimulation and targeted delivery of therapeutic molecules.

Unlike an ordinary comb, its specially engineered teeth contain tiny electrodes and drug-delivery modules. The electrodes generate controlled electrical pulses as the device moves across the treated area.

These electrical fields help therapeutic molecules penetrate deeper into the skin and reach hair follicles more effectively. According to the researchers, the system can generate electric fields that penetrate up to nine times deeper into follicular regions than conventional external application.

The treatment combines two experimental biological components.

The first is a VEGFA-encoding plasmid designed to encourage the formation of blood vessels around hair follicles, potentially improving their supply of oxygen and nutrients.

The second is an RNA-based treatment, known as SRD5A2-targeting siRNA, designed to reduce the production of an enzyme involved in converting testosterone into DHT.

By combining electrical stimulation with these two treatments, the researchers aimed to support follicle activity while addressing hormonal processes associated with pattern hair loss.

What Did the 28-Day Experiment Reveal?

The researchers tested the device on male mice with experimentally induced androgenetic alopecia. The animals received treatment on shaved areas of their backs, with the experimental procedure repeated every three days.

The results showed a considerable difference between the treatment groups.

Mice receiving the complete Detangle treatment achieved approximately 97.85% hair coverage in the treated area after 28 days.

By comparison, mice receiving topical minoxidil achieved approximately 70% coverage. Those treated with finasteride showed around 50% regrowth, while electrical stimulation alone produced approximately 40%.

Untreated mice showed only about 1% regrowth during the same experimental period.

The researchers also observed improvements in hair follicle numbers and local blood circulation among animals receiving the combined treatment.

These findings suggest that combining electrical stimulation with targeted delivery could be more effective than relying on topical medication alone in this particular animal model.

Can the Electronic Comb Cure Baldness in Humans?

Despite the encouraging results, Detangle is not yet a clinically proven treatment for human baldness.

The experiment was conducted on mice with artificially induced hair loss. Human hair follicles, scalp biology and patterns of androgenetic alopecia are more complex. Results obtained in laboratory animals cannot automatically be translated into similar outcomes in people.

Several questions also remain unanswered. Researchers must establish whether the device is safe for repeated use on the human scalp, whether its therapeutic molecules produce lasting benefits, and whether hair regrowth can be maintained over time.

Human clinical trials will be necessary to determine its actual effectiveness, appropriate treatment schedule and potential side effects. The study does not establish a timeline for commercial availability.

For now, people experiencing hair loss should not abandon established medical advice or existing treatments in anticipation of this experimental technology.

A Promising Direction for Hair-Regrowth Research

The significance of Detangle lies in its approach to combining everyday grooming with advanced biomedical technology. Instead of depending entirely on conventional topical applications, the device attempts to stimulate follicles and deliver therapeutic molecules directly to their target areas.

If future human trials establish its safety and effectiveness, this technology could open another avenue in the treatment of pattern baldness.

For the more than 1.5 billion people estimated to experience androgenetic alopecia, the research offers a reason for scientific optimism. But the distance between nearly complete hair coverage in laboratory mice and a reliable treatment for human baldness remains considerable.

 

Stay Updated with InsightfulTake

Get insightful stories, politics, culture and analysis directly in your inbox.

Subscribe Now →

Leave a Comment